
China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS
600062.SS
China Resources Double-Crane Pharmaceutical Co.,Ltd. 600511.SS
China National Medicines Corporation Ltd. 000739.SZ
Apeloa Pharmaceutical Co.,Ltd 600380.SS
Joincare Pharmaceutical Group Industry Co.,Ltd. 600566.SS
Hubei Jumpcan Pharmaceutical Co., Ltd. 603858.SS
Shandong Buchang Pharmaceuticals Co., Ltd. 603707.SS
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 603456.SS
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 000623.SZ
Jilin Aodong Pharmaceutical Group Co., Ltd. 600211.SS
Tibet Rhodiola Pharmaceutical Holding Co.
China Resources Double-Crane Pharmaceutical Co.,Ltd. 600511.SS
China National Medicines Corporation Ltd. 000739.SZ
Apeloa Pharmaceutical Co.,Ltd 600380.SS
Joincare Pharmaceutical Group Industry Co.,Ltd. 600566.SS
Hubei Jumpcan Pharmaceutical Co., Ltd. 603858.SS
Shandong Buchang Pharmaceuticals Co., Ltd. 603707.SS
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 603456.SS
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 000623.SZ
Jilin Aodong Pharmaceutical Group Co., Ltd. 600211.SS
Tibet Rhodiola Pharmaceutical Holding Co.
Performance
Periode | 600062.SS | 600511.SS | 000739.SZ | 600380.SS | 600566.SS | 603858.SS | 603707.SS | 603456.SS | 000623.SZ | 600211.SS |
---|---|---|---|---|---|---|---|---|---|---|
6M | 3.59 % | -2.22 % | 18.13 % | 16.35 % | -3.71 % | 22.34 % | -6.21 % | 41.96 % | 30.38 % | 31.45 % |
YTD | -2.80 % | -12.68 % | 3.02 % | 10.10 % | -10.55 % | 15.58 % | -20.82 % | 41.01 % | 23.39 % | 35.69 % |
1Y | -21.18 % | -12.43 % | 1.39 % | 11.21 % | -15.82 % | 4.77 % | -32.03 % | 24.54 % | 22.28 % | 22.98 % |
3Y | 3.25 % | 10.90 % | -22.26 % | 2.63 % | -12.57 % | -2.41 % | -41.41 % | -53.31 % | 48.23 % | 80.21 % |
5Y | 44.98 % | -40.81 % | -26.54 % | -29.86 % | 9.53 % | -30.03 % | -55.07 % | -44.54 % | 17.58 % | -29.00 % |
10Y | 19.64 % | -15.54 % | 114.59 % | 2.80 % | 5.98 % | -62.62 % | 266.79 % | 19.45 % | -1.30 % | 137.68 % |
From the beginning | 493.67 % | 1 057.49 % | 895.65 % | 157.45 % | 55.85 % | -62.62 % | 266.79 % | 207.62 % | 1 212.18 % | 472.58 % |